COMPARING THERAPEUTIC EFFECTS OF REBOXETINE WITH PLACEBO IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RIAHI F.; SHAHRIVAR Z.; TEHRANI DOUST M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Jundishapur Scientific Medical Journal Year:2010 | Volume:9 | Issue:5 (68) Page(s): 483-493

Download Full-Text

Persian Verion

View:

615

Download:

Cites:

Information Journal Paper

Title

COMPARING THERAPEUTIC EFFECTS OF REBOXETINE WITH PLACEBO IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Author(s)

RIAHI F. | SHAHRIVAR Z. | TEHRANI DOUST M. | Issue Writer Certificate

Keywords

ATTENTION-DEFICIT/HYPERACTIVITY DISORDERQ3

REBOXETINEQ3

CONNER'S ADHD RATING SCALEQ3

Abstract

Background and Objective: Attention-deficit-hyperactivity disorder (ADHD) in adults is accompanied with different complications such as decreased occupational and educational performance. At present, stimulant drugs are used as the first line treatment in this disorder. However, possible development of side effects and dependence on these drugs are of concern. Therefore, it was decided to evaluate the efficacy of REBOXETINE in the treatment of adults with attention-deficit-hyperactivity disorder.Subjects and Methods: Forty adult diagnosed with ADHD without any significant psychiatric disorder were participated in a 6-weeks a double blind clinical trial with REBOXETINE (8 mg/d) in two divided doses. The principle measured outcome was the CONNER'S ADHD RATING SCALE (adult version).Results: Rate of response (decrease of Conner’s rating scale scores) in REBOXETINE group were significantly greater than control group (p<0.001).Conclusion: REBOXETINE may be an effective treatment for the adult with attention-deficit/ hyperactivity disorder.

Cites

No record.

References

No record.

Cite

APA: Copy

RIAHI, F., SHAHRIVAR, Z., & TEHRANI DOUST, M.. (2010). COMPARING THERAPEUTIC EFFECTS OF REBOXETINE WITH PLACEBO IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, 9(5 (68)), 483-493. SID. https://sid.ir/paper/12709/en

Vancouver: Copy

RIAHI F., SHAHRIVAR Z., TEHRANI DOUST M.. COMPARING THERAPEUTIC EFFECTS OF REBOXETINE WITH PLACEBO IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL[Internet]. 2010;9(5 (68)):483-493. Available from: https://sid.ir/paper/12709/en

IEEE: Copy

F. RIAHI, Z. SHAHRIVAR, and M. TEHRANI DOUST, “COMPARING THERAPEUTIC EFFECTS OF REBOXETINE WITH PLACEBO IN ADULT PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL,” JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, vol. 9, no. 5 (68), pp. 483–493, 2010, [Online]. Available: https://sid.ir/paper/12709/en

Related Journal Papers